Study targets ‘cancer gene’

A genetic mutation found to be quite prevalent among lung cancer patients in Ireland could be successfully targeted with new therapies, it has emerged.

Research funded by the Irish Cancer Society explored the incidences of certain genetic mutations in lung cancer patients.

It identified a gene called PIK3CA that appears to be quite high among the Irish population, compared with international rates.